Arno Therapeutics, Inc.
ARNI · OTC
9/30/2016 | 6/30/2016 | 3/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Market Cap | $21,012 | $12,968 | $14,734 | $7,041 |
| - Cash | $2,124 | $937 | $2,684 | $67 |
| + Debt | $5 | $6 | $7 | $2,098 |
| Enterprise Value | $18,893 | $12,036 | $12,057 | $9,072 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,847 | -$2,140 | -$2,821 | -$2,694 |
| % Margin | – | – | – | – |
| Net Income | -$3,849 | -$2,143 | -$3,723 | -$4,022 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.086 | -0.052 | -0.096 | -0.2 |
| % Growth | -66.9% | 46.3% | 52% | – |
| Operating Cash Flow | -$1,140 | -$1,680 | -$2,655 | -$2,143 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,140 | -$1,680 | -$2,655 | -$2,143 |